Singapore healthtech startup injewelme raised $1.2 M to improve AI monitoring technology
In a press release, Temasek Trust’s catalytic investment vehicle, Catalytic Capital for Climate and Health (C3H), announced that it had led a US$1.2 million funding round for Singapore-based AI healthtech startup injewelme.
The UK-based Richardson family, an independent, multigenerational trading and investment company, also participated in the round. Co-Axis also helped the startup find investors. According to injewelme, the funding will help it achieve its objectives of increasing access to ongoing, data-driven health monitoring and developing the application of AI in preventive healthcare.
The money will go toward improving injewelme’s DeepHealthVision (DHV) technology, including making it more capable of measuring other health indicators like blood sugar, stress, fatigue, and hydration. Injewelme’s expansion plans in Singapore and other Southeast Asian markets will also be aided by the recently raised funds. The company wants to improve its capacity to track the impacts of climate-related stress while expanding applications across industries.
With the use of a standard camera and remote photoplethysmography (rPPG), injewelme’s DHV platform allows contactless monitoring of over 20 critical health parameters, such as blood pressure, oxygen saturation, and heart rate, in about 30 seconds. With a reported detection accuracy of 95% in real-world pilot programs, the system is powered by proprietary software and predictive artificial intelligence models.
The business has already run live pilot programs, and some partners are looking into wider adoption. SJ Integrated Solutions is one such partner that has employed the technology as a contactless screening tool in senior wellness and fitness programs.
